Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 144 | 190 | -667 | 0 | 0 |
Gross Profit | 144 | 190 | -667 | N/A | N/A |
Operating Expenses | 20,584 | 21,283 | 20,339 | 15,495 | 17,176 |
Operating Income | -20,440 | -21,093 | -21,006 | -15,495 | -17,176 |
Other Income | 23,338 | -62,845 | -16,673 | -26,875 | -12,401 |
Pre-tax Income | 2,898 | -83,938 | -37,679 | -42,370 | -29,577 |
Net Income Continuous | 2,898 | -83,938 | -37,679 | -42,370 | -29,577 |
Net Income | $2,898 | $-83,938 | $-37,679 | $-42,370 | $-29,577 |
EPS Basic Total Ops | 0.02 | -0.67 | -0.40 | -0.47 | -0.37 |
EPS Basic Continuous Ops | 0.02 | -0.67 | -0.40 | -0.47 | -0.37 |
EPS Diluted Total Ops | -0.13 | -0.67 | -0.40 | -0.47 | -0.37 |
EPS Diluted Continuous Ops | 0.02 | -0.67 | -0.40 | -0.47 | -0.37 |
EPS Diluted Before Non-Recurring Items | -0.13 | -0.16 | -0.33 | -0.47 | -0.37 |
EBITDA(a) | $-20,136 | $-20,589 | $-20,612 | $-14,988 | $-16,492 |